& çâÌæÚUæð´ ·¤è ¥ôÚU Îð¹Ùæ ÁæÚUè ÚU¹ð´ ¥ÍæüÌ ¥ÂÙð ÜÿØ ÂÚU ŠØæÙ ÚU¹ð´Ð ãæÚU Ù ×æÙð´, €UØô´ç·¤ ·¤æ× ·¤ÚUÙð âð ¥æÂ·¤ô ©gðàØ ·¤è Âýæç# ãôÌè ãñ ¥õÚU ÁèßÙ ·¤æ ¹æÜèÂÙ ÎêÚU ãôÌæ ãñÐ ÖÜð ãè ÁèßÙ ×ð´ ç·¤ÌÙè Öè ·¤çÆÙæ§ü €UØô´ Ù ¥æ°, çÁ™ææâæ ¥õÚU ©ˆâæã ÕÙæ° ÚU¹ð´Ð ŠØæÙ ÚU¹ð´, ÜÿØ ã×ðàææ ¥æÂ·Ô¤ Âæâ ãôÌð ãñ´ çÁ‹ãð´ ÂæÙð ·Ô¤ çÜ° ÂýØæâ ¥æÂ ·¤Öè Öè àæéM¤ ·¤ÚU â·¤Ìð ãñ´Ð

KSA HEALTH MINISTER VISITS TWO PHARMA PLANTS

Saudi Arabia shows interest in Bangladesh medicine

UNB, Dhaka
A 3-day trip of a high-level Saudi delegation led by its health minister brightened the prospect of medicine export to the kingdom as it gave initial indication of importing medicines from Bangladesh.
Saudi Health Minister Dr Hamad Bin Abdullah Al-Manea expressed satisfaction over the production capability, facilities and environment in the pharmaceutical industries they visited in Dhaka yesterday.
Giving his instant reaction to newsmen after inspecting two premier drug-manufacturing industries in Dhaka, Dr Al-Manea said he was happy with production setup and environment in the two factories.
Replying to a question, he expressed hope for the import of drugs from Bangladesh.
The Saudi health minister, how-
ever, said his country would take a decision after the trip by another technical delegation comprising mainly drug experts to ascertain the quality of drugs.
The technical team will arrive in Dhaka within next two weeks while the present delegation left Dhaka yesterday.
Bangladesh Health Minister Dr Khandokar Mosharraf Hossain who accompanied his counterpart during the visit to the two pharma-factories said the spot inspection would have positive impact regarding the import of medicines by Saudi Arabia from Bangladesh as they will send another technical team soon.
Replying to a question, he said the present delegation did not come to sign any agreement but to have a look at the facilities and standard of health services and manufacturing of drugs in Bangladesh.
"The delegation has understood that standard medicines are being
manufactured in Bangladesh," said the minister.
Dr Mosharraf hoped that their visit would be fruitful with regard to exporting drugs to Saudi Arabia.
The Saudi Health Minister, along with the five members of his delegation, visited Beximco Pharma factory at Tongi and Incepta Pharmaceutical Industry at Savar in Dhaka.
The Saudi health minister, Dr Al-Manea, first drove to Beximco Pharma factory around 10am where its Chief Executive Officer Nazmul Hasan displayed and briefed about the pharmaceuticals they produce.
According to pharmaceutical industry owners, some 200 pharmaceutical industries are in operation in Bangladesh of which 20 leading factories are producing internationalstandard medicines.
Beximco Pharma is now manufacturing 142 drugs of different dosages with annual turnover of 50 million US dollars.
During the presentation he said Beximco exports major drugs, including inhaler, to many countries, including Singapore, Russia, Pakistan, South Korea, Vietnam, Nepal and Kenya.
The Saudi delegation inspected some production units at the Beximco Pharma, including IV fluid plant, and also some production units at the Incepta factory.
Incepta Managing Director Abdul Muktadir presented documentation about the performance and production facilities, qualities and their policy.
The pharmaceutical company, formally launched in January 2000, now produces 207 items of drugs and is in the pipeline of exporting its products.
Muktadir said his company could ensure 100 percent international standards of their products.